|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Arizona Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing ArizonaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amneal Pharmaceuticals, Inc.
| | | Phone: | (215) 613-2400 | Fax: | (215) 613-2406 | Year Established: | 1999 | Ticker: | AMRX | Exchange: | NYSE | Main Contact: | Robert Stewart, President & CEO | | Other Contacts: | Bryan M. Reasons, Senior VP & CFO Deb M. Penza, Senior VP, Chief Compliance Officer Scott L. Hunter, VP, Specialty Sales and Marketing Sheldon Hirt, Senior VP, General Counsel Joseph Greer, Senior VP, Global Quality Management Miguel Gomez, Senior VP, Technical Operations Shankar Hariharan, Ph.D., Executive VP & CSO Robert Stewart, President Andrew S. Boyer, Executive VP, Commercial Operations
| | Company Description | Amneal Pharmaceuticals, formerly Impax Laboratories, is a U.S.-based developer and manufacturer of high quality generic pharmaceuticals globally. The Company owns and operates manufacturing, R&D, packaging, sales and distribution facilities throughout the U.S. and abroad. | |
|
|
|
|
|